Wellington Management Group LLP Biotechnology

Wellington Management Group LLP

$503 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ARCT Arcturus Therapeutics Holdings Inc.	$355M	$983,000 0.0% of portfolio	92,874	Q1 2025 New
TYRA Tyra Biosciences, Inc.	$408M	$968,000 0.0% of portfolio	104,087	Q1 2025 New
AVIR Atea Pharmaceuticals, Inc.	$303M	$910,000 0.0% of portfolio	304,530	Q1 2025 New
STOK Stoke Therapeutics, Inc.	$461M	$904,000 0.0% of portfolio	135,960	Q1 2025 New
YMAB Y M Abs Therapeutics, Inc.	$184M	$903,000 0.0% of portfolio	204,052	Q1 2025 New
TERN Terns Pharmaceuticals, Inc.	$167M	$886,000 0.0% of portfolio	321,163	Q1 2025 New
GLUE Monte Rosa Therapeutics, Inc.	$232M	$871,000 0.0% of portfolio	187,731	Q1 2025 New
TSHA Taysha Gene Therapies, Inc.	$117M	$869,000 0.0% of portfolio	625,198	Q1 2025 New
ACAD Acadia Pharmaceuticals Inc	$3.54B	$859,000 0.0% of portfolio	51,775	Q1 2025 New
CELC Celcuity Inc.	$200M	$857,000 0.0% of portfolio	84,825	Q1 2025 New
VYGR Voyager Therapeutics, Inc.	$122M	$856,000 0.0% of portfolio	253,314	Q1 2025 New
ITOS I Teos Therapeutics, Inc.	$358M	$836,000 0.0% of portfolio	140,119	Q1 2025 New
ATXS Astria Therapeutics, Inc.	$97.3M	$814,000 0.0% of portfolio	152,611	Q1 2025 New
AURA Aura Biosciences, Inc.	$180M	$814,000 0.0% of portfolio	138,952	Q1 2025 New
ABSI Absci Corp	$248M	$811,000 0.0% of portfolio	323,119	Q1 2025 New
TRVI Trevi Therapeutics, Inc.	$343M	$801,000 0.0% of portfolio	127,452	Q1 2025 New
FDMT 4 D Molecular Therapeutics, Inc.	$132M	$799,000 0.0% of portfolio	247,471	Q1 2025 New
LGND Ligand Pharmaceuticals Inc	$2.14B	$795,000 0.0% of portfolio	7,562	Q1 2025 New
SMMT Summit Therapeutics Inc.	$4.61B	$781,000 0.0% of portfolio	40,492	Q1 2025 New
ARQT Arcutis Biotherapeutics, Inc.	$957M	$729,000 0.0% of portfolio	46,640	Q1 2025 New
TSVT 2seventy Bio, Inc.	$189M	$729,000 0.0% of portfolio	147,663	Q1 2025 New
ABEO Abeona Therapeutics Inc.	$34.8M	$728,000 0.0% of portfolio	153,121	Q1 2025 New
AGIO Agios Pharmaceuticals, Inc.	$2.15B	$716,000 0.0% of portfolio	24,462	Q1 2025 New
KMPH Kempharm, Inc	$170M	$693,000 0.0% of portfolio	140,418	Q1 2025 New
ANNX Annexon, Inc.	$131M	$688,000 0.0% of portfolio	356,480	Q1 2025 New
IMVT Immunovant, Inc.	$3.55B	$688,000 0.0% of portfolio	25,030	Q1 2025 New
BCRX Biocryst Pharmaceuticals Inc	$1.67B	$685,000 0.0% of portfolio	91,348	Q1 2025 New
ALDX Aldeyra Therapeutics, Inc.	$248M	$675,000 0.0% of portfolio	117,475	Q1 2025 New
ARWR Arrowhead Pharmaceuticals, Inc.	$1.97B	$670,000 0.0% of portfolio	52,614	Q1 2025 New
BEAM Beam Therapeutics Inc.	$1.44B	$656,000 0.0% of portfolio	33,631	Q1 2025 New
ELDN Eledon Pharmaceuticals, Inc.	$47M	$638,000 0.0% of portfolio	188,485	Q1 2025 New
IDYA Ideaya Biosciences, Inc.	$1.02B	$597,000 0.0% of portfolio	36,486	Q1 2025 New
TVTX Travere Therapeutics, Inc.	$1.09B	$594,000 0.0% of portfolio	33,170	Q1 2025 New
RXRX Recursion Pharmaceuticals, Inc.	$953M	$568,000 0.0% of portfolio	107,476	Q1 2025 New
DSGN Design Therapeutics, Inc.	$198M	$546,000 0.0% of portfolio	141,519	Q1 2025 New
HRMY Harmony Biosciences Holdings, Inc.	$2.05B	$542,000 0.0% of portfolio	16,357	Q1 2025 New
HUMA Humacyte, Inc.	$249M	$531,000 0.0% of portfolio	310,777	Q1 2025 New
ARDX Ardelyx, Inc.	$693M	$500,000 0.0% of portfolio	101,975	Q1 2025 New
VERA Vera Therapeutics, Inc.	$619M	$457,000 0.0% of portfolio	19,061	Q1 2025 New
AUPH Aurinia Pharmaceuticals Inc.	$1.28B	$443,000 0.0% of portfolio	55,190	Q1 2025 New
INVA Innoviva, Inc.	$1.36B	$442,000 0.0% of portfolio	24,397	Q1 2025 New
SNDX Syndax Pharmaceuticals Inc	$557M	$441,000 0.0% of portfolio	35,962	Q1 2025 New
CMPX Compass Therapeutics, Inc.	$270M	$422,000 0.0% of portfolio	222,505	Q1 2025 New
NVAX Novavax Inc	$545M	$418,000 0.0% of portfolio	65,293	Q1 2025 New
IOVA Iovance Biotherapeutics, Inc.	$317M	$396,000 0.0% of portfolio	119,008	Q1 2025 New
DYN Dyne Therapeutics, Inc.	$423M	$379,000 0.0% of portfolio	36,322	Q1 2025 New
FHTX Foghorn Therapeutics Inc.	$199M	$375,000 0.0% of portfolio	102,888	Q1 2025 New
CRVS Corvus Pharmaceuticals, Inc.	$182M	$333,000 0.0% of portfolio	104,872	Q1 2025 New
ETON Eton Pharmaceuticals, Inc.	$395M	$328,000 0.0% of portfolio	25,283	Q1 2025 New
XNCR Xencor Inc	$528M	$316,000 0.0% of portfolio	29,776	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.